The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand
2 other identifiers
interventional
42
1 country
6
Brief Summary
This project explores the feasibility of using automated telephone calls to adult patients with type 2 diabetes to improve diabetes self-management in Thailand. This line of work could significantly extend Thai nurses' ability to manage this growing epidemic, and ultimately reduce the suffering and costs caused by diabetes in Thailand.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Jun 2017
Shorter than P25 for not_applicable type-2-diabetes-mellitus
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2017
CompletedFirst Posted
Study publicly available on registry
March 13, 2017
CompletedStudy Start
First participant enrolled
June 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 22, 2017
December 1, 2017
6 months
March 7, 2017
December 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HbA1c
It refers to glycated haemoglobin, which identifies average plasma glucose concentration.
13 weeks
Diabetes related distress
It will be measured using the emotional and regimen subscales of a Thai translation of the well-validated Diabetes Distress Scale. This is a reliable and validated scale, and correlates with other measures of emotional distress. The responses range from 1-6. The higher scores indicate a greater degree of distress.
13 weeks
Secondary Outcomes (1)
Fasting blood glucose
13 weeks
Other Outcomes (13)
Sleep quality
13 weeks
Dietary consumption
13 weeks
Physical activity
13 weeks
- +10 more other outcomes
Study Arms (2)
Patient Arm using mHealth
EXPERIMENTALPatients with uncontrolled type 2 diabetes
Community nurses
EXPERIMENTALNurses who receive mHealth report about patients in the patients' arm.
Interventions
Patients will receive weekly automated IVR telephone calls for 12 weeks to assess their glycemic symptoms, medication adherence, dietary consumption, physical activity, sleep, and foot care. These 5-10 minute calls will follow a standardized Thai language IVR script developed specifically for this study.
Nurses will also receive a technical troubleshooting guide, and have similar access to live telephone technical support. Once their patients' calls begin, nurses will begin receiving weekly e-mail reports summarizing each patients' assessment results, any active self-management problems the patients reported, and suggested strategies for supporting the patient's self-management.
Eligibility Criteria
You may qualify if:
- For patients:
- poorly controlled type 2 diabetes as indicated by HbA1c ≥ 7.5% recorded within past 6 months
- aged 20 years and older
- currently being treated by oral antihyperglycemic
- communicates and reads in Thai
- has access to and able to use a touch-tone phone (either a land line or a mobile phone)
- free of major physical, cognitive, or psychiatric impairment (per medical records and PI discretion) that would prevent them from participating meaningfully in the intervention.
- For nurses:
- works in a non-communicable disease clinic.
- can access email
- has a mobile telephone.
You may not qualify if:
- For patients:
- have participated in other mHealth interventions within 3 months
- have baseline HbA1c \< 7.5%
- are hospitalized or otherwise at risk for hospitalization
- are prescribed injected insulin
- patients and nurses who participated in the usability trial will be ineligible to participate in the pilot trial.
- For nurses: None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- Mahidol Universitycollaborator
- Fogarty International Center of the National Institute of Healthcollaborator
Study Sites (6)
Buengbon Health Promoting Hospital
Nong Suea, Changwat Pathum Thani, 12170, Thailand
Buengkasam 1 Health Promoting Hospital
Nong Suea, Changwat Pathum Thani, 12170, Thailand
Buengkasam 2 Health Promoting Hospital
Nong Suea, Changwat Pathum Thani, 12170, Thailand
Buengshamaor 1 Health Promoting Hospital
Nong Suea, Changwat Pathum Thani, 12170, Thailand
Nongsamwang 1 Health Promoting Hospital
Nong Suea, Changwat Pathum Thani, 12170, Thailand
Salakru Health Promoting Hospital
Nong Suea, Changwat Pathum Thani, 12170, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Panan Pichayapinyo, PhD.
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 7, 2017
First Posted
March 13, 2017
Study Start
June 9, 2017
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
December 22, 2017
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share